Insulin-like growth factor I (IGF-I) and its associated binding proteins (IGFBPs) (BrJ7 Ophthalmol 1994; 78: 638-642) 
Abstract
Insulin-like growth factor I (IGF-I) and its associated binding proteins (IGFBPs) have been identified in retinal tissues but their precise cellular origin remains unclear. The aim of this study was to examine the ability of three retinal cell types (microvascular endothelial cells, pericytes, and pigment epithelial cells) and a non-retinal cell type (Tenon's fibroblasts) to produce IGF-I and cell specific IGFBPs in vitro. Using a radioimmunoassay we demonstrated that all four cell types produce IGF-I and that this production continued over a 72 hour period. In addition, western ligand blotting revealed that each cell type produced at least one IGFBP and that each cell type produced a different IGFBP profile. Endothelial cells produced a 24 kDa band only, pericytes produced both a 24 kDa and a 34 kDa band, retinal pigment epithelial cells produced a 38-41 kDa band, while fibroblasts produced both a 24 kDa and a 30 kDa band. Laser scanning densitometry demonstrated that in the majority of experiments the IGFBPs accumulated in the culture medium over a 72 hour period. Neither IGF-I nor IGFBPs were observed in cell lysates indicating de novo synthesis and secretion in vitro. These results suggest an autocrine/paracrine function for IGF-I and its associated binding proteins which may play a significant role in both retinal physiology and disease. (BrJ7 Ophthalmol 1994; 78: 638-642) Insulin-like growth factor I (IGF-I) is a polypeptide which stimulates the growth, differentiation, and metabolism of a variety of cell types.' Its activity is controlled in a complex mannerfor example, IGF-I expression in most tissues is known to be influenced by hormonal, nutritional, tissue specific, and developmental factors. [2] [3] [4] [5] In addition it appears that the growth promoting effects of many circulating hormones may be mediated via the stimulation of local IGF-I production. ' IGF-I activity in extracellular fluids is carefully controlled by its association with insulin-like growth factor binding proteins (IGFBPs University) at a dilution of 1:37500. Reagent additions were carried out on ice and the tubes were incubated overnight at 4°C. After incubation, 100 >t of anti-rabbit IgG coated with cellulose (IDS) was added to each reaction tube except those for total counts. The mixtures were incubated for 1 hour at 37°C. Thereafter, 0-5 ml of RIA buffer was added and the tubes were centrifuged at 1850 g for 15 minutes. The supernatant was discarded, and the pellet was assayed on a gammacounter. In addition, endogenous levels of IGF-I were determined in plasma-containing media which had not been exposed to cells. WESTERN 
Results
All cell types maintained under plasma-free conditions released detectable levels of IGF-I throughout the time course of this study (Fig 1) . However, IGF-I production in plasmacontaining media was restricted to the RPE cells and only at the 72 hour time point by which time IGF-I levels were greater than the endogenous level in plasma-containing medium (15 (SD 1) ng/ml). The release of IGF-I into plasma-free medium varied between cell types (Fig 1) . Both pericytes and RPE cells continually produced IGF-I throughout the time course of the study. Each cell type studied produced a distinct IGFBP profile which was identical in both the plasma-containing and plasma-free media (Fig  2) , however, the production of IGFBPs in plasma-free medium was greatly reduced compared with that in plasma-containing medium. In the case of plasma-containing media IGFBP profiles were clearly distinguishable from the endogenous IGFBPs in the plasma (predominantly a 38-41 kDa band). No (Figs 3-6 ; Table I ). In all cases IGFBP accumulation in the culture media was greatest at the 72 hour time point, but the rate of accumulation varied with cell type. Ultrascan data for endothelial cell production ofthe 24 kDa IGFBP showed a slight variation between the two types of media; production in the plasma-containing media was continuous and similar to that observed for their production of IGF-I (Fig 1) , while production in the plasma-free media increased steadily from 12 to 48 hours whereupon the levels of IGFBP remained constant. By contrast, retinal pericyte production of the predominant 34 kDa and the 24 kDa IGFBP depicted similar trends of accumulation in both media types (that is, the production of both increased steadily as a function of time).
Production of the 38-41 kDa IGFBP by RPE cells appeared to follow no trend in the plasmacontaining media, whereas in the plasma-free media production increased rapidly with time (identical to RPE production of IGF-I). Fibroblast production of both the 30 kDa and 24 kDa IGFBPs peaked at 48 hours in the plasmacontaining media, after which time it decreased dramatically (indicative of proteolytic degradation). By contrast, production of the 30 kDa IGFBP remained relatively constant after 12 hours of production in the plasma-free medium (although a peak of production was observed at 72 hours); after a 6 hour lag period production of the 24 kDa IGFBP was continuous with time in the plasma-free media. Figure 6 Western ligand blot showing the production of both the 30 and 24 kDa IGFBPs by Tenon's fibroblasts over a 72 hour time course. The time course experiments were carried out in the presence (+plasma) and the absence (-plasma) ofplasma. This autoradiograph was representative ofthree separate experiments. 29 who have demonstrated that both retinal microvascular endothelial cells and RPE cells produce IGF-I in vitro. It is difficult to make comparisons between the levels of IGF-I produced in the various studies owing to the different extraction procedures used before radioimmunoassay and the different cell culture conditions (it is likely that the levels of IGF-I produced by individual cell types are media dependent). While observing different levels of IGF-I production between human and bovine cells this study does not take into account possible species specific, post-translational modification of IGF-I that may occur in bovine cells when compared with human cells.
The apparent lack of production of IGF-I in serum/plasma-containing media is supported by (a) Brooks et a128 who observed IGF-I production by bovine microvascular cells in serum-free medium but failed to observe IGF-I production in serum-containing medium, and (b) Lowe et al30 who concluded that serum factors may inhibit IGF-I production. This discrepancy between IGF-I levels in plasma-free versus plasma-containing medium can be explained in one of two ways. Firstly, there may be negative feedback on the production of IGF-I by retinal cells owing to the presence of endogenous IGF-I in the plasma (15 ng/ml) as postulated by Brooks et al. However, this is unlikely since IGF-I production was observed in plasma-free medium at IGF-I levels greater than 40 ng/ml. It is possible, however, that other endogenous factors in plasma are capable ofinhibiting IGF-I production; transforming growth factor B has been shown to downregulate IGF-I production in vitro.3' Secondly, the inability to measure IGF-I in plasma-containing media may be due to the effect ofplasma on the extraction procedure. The sensitivity of the RIA is reduced 15-fold when IGF-I extraction is undertaken in the presence of plasma as opposed to plasma-free medium (results not shown). Thus it is plausible that the cells were indeed secreting IGF-I in the plasmacontaining medium but that it remained below the sensitivity of the RIA. Support for this explanation comes from the fact that IGFBP secretion was seen in both the plasma-containing and plasma-free media.
This study is the first to demonstrate that retinal cells secrete cell-specific IGFBP 
